Full text is available at the source.
Therapie des Typ-2-Diabetes
Treatment recommendations for type 2 diabetes from the European diabetes association
AI simplified
Abstract
New clinical recommendations emphasize cardiovascular risk over HbA1c levels in treating type 2 diabetes patients.
- Individual patient profiles and cardiovascular risk are prioritized in treatment strategies.
- For patients at high or very high cardiovascular risk, GLP-1 receptor agonists or SGLT-2 inhibitors are recommended.
- SGLT-2 inhibitors are specifically highlighted for patients with chronic heart failure or those at increased cardiovascular risk.
AI simplified